SANDRA ASH: Open Payments
NPI 1891305256 · MOUNT HOLLY, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$179 in 10 payments from 7 companies in 2025. Trend: 2023 $60 · 2024 $129 · 2025 $179
Food & beverage: $179
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 2 | $37 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $31 |
| Ipsen Biopharmaceuticals, Inc | 1 | $23 |
| Madrigal Pharmaceuticals | 1 | $20 |
| Celltrion USA Inc. | 1 | $19 |
| ABBVIE INC. | 1 | $16 |
Products named: TREMFYA, XIFAXAN, ENTYVIO, IQIRVO, REZDIFFRA, VEGZELMA, LINZESS.
Industry payments across NJ — which companies pay providers there.
